2-(4,6-Bis(2,4-dimethylphenyl)-1,3,5-triazin-2-yl)-5-(octyloxy)phenol, 98%, 500g

Trial kit Spectra/Por® Biotech CE, 8000–10000 dalton(s), 1 Piece(s)

6-Chloro-1h-pyrrolo[3,2-b]pyridine-3-carbaldehyde, 98+%, 250mg

Poly(4-hydroxy-2,2,6,6-tetramethyl-1-piperidineethanol-alt-1,4-butanedioic acid), 95.0%, 100g

N'-[1-Cyclobutylamino-2-phenylethylidene]hydrazinecarboxylic acid tert-butylester, 95.0%, 500mg

Methyl 4-iodo-2-nitrobenzoate, 97%, 5g

1-(tert-Butyl) 2-methyl (2S,4S)-4-(hydroxymethyl)pyrrolidine-1,2-dicarboxylate, 98%, 250mg

1,3-BIS[4-(TERT-BUTYL)PHENYL]-2,2-BIS[(S)-4-PHENYL-4,5-DIHYDRO-2-OXAZOLYL]PROPANE, 95%, 1g

3-Nitro-4-piperazin-1-yl-benzoic acid methyl ester, 1g

Ethanamine, 2-[(8-chlorodibenzo[b,f]thiepin-10-yl)oxy]-N,N-dimethyl-, 98%, 10mg

5-IODO-2-(TRIFLUOROMETHYL)BENZONITRILE, 95.0%, 5g

7-Chloro-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid, 98%, 100mg

3-Chloro-3-(4-chlorophenyl)acrylonitrile, 1g